Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M C Rubio Calvo

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Antimicrobial Agents and Chemotherapy|September 1, 1975
Third type of plasmid conferring gentamicin resistance in Pseudomonas aeruginosaD I Smith, R G Lus, M C Rubio Calvo, et al.
Drugs Under Experimental and Clinical Research|January 1, 1989
Stability of dactimicin to aminoglycoside-modifying enzymes produced by 341 bacterial clinical isolatesR Gómez-Lus, S Gómez-Lus, M P Goñi, et al.
The Journal of International Medical Research|January 1, 1980
A study of erythromycin activity in vivoR Gomez Lus, M C Rubio Calvo, P E Davis, et al.
International Journal of Antimicrobial Agents|June 15, 2004
Macrolide resistance phenotypes of commensal viridans group streptococci and Gemella spp. and PCR detection of resistance genesP Cerdá Zolezzi, M C Rubio Calvo, L Millán, et al.
Revista De Sanidad E Higiene Publica|May 1, 1978
[Epidemiological indicators]R Gómez-Lus, M C Rubio Calvo, L Gómez López, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Antimicrobial Agents and Chemotherapy|September 1, 1975
Third type of plasmid conferring gentamicin resistance in Pseudomonas aeruginosaD I Smith, R G Lus, M C Rubio Calvo, et al.
Drugs Under Experimental and Clinical Research|January 1, 1989
Stability of dactimicin to aminoglycoside-modifying enzymes produced by 341 bacterial clinical isolatesR Gómez-Lus, S Gómez-Lus, M P Goñi, et al.
The Journal of International Medical Research|January 1, 1980
A study of erythromycin activity in vivoR Gomez Lus, M C Rubio Calvo, P E Davis, et al.
International Journal of Antimicrobial Agents|June 15, 2004
Macrolide resistance phenotypes of commensal viridans group streptococci and Gemella spp. and PCR detection of resistance genesP Cerdá Zolezzi, M C Rubio Calvo, L Millán, et al.
Revista De Sanidad E Higiene Publica|May 1, 1978
[Epidemiological indicators]R Gómez-Lus, M C Rubio Calvo, L Gómez López, et al.
Pageof 2